Liputan6.com, Jakarta Internal medicine specialist who is also a vaccinologist Dirga Sakti Rambe said that the manufacture of an vaccine requires a long and complicated process. This is done in order to maintain the quality and safety of vaccines.
“Don’t imagine drugs being mixed in a bowl. (Making vaccine) Starting from the growth of the virus / bacteria, we harvest it, we formulate it, wash it millions of times, until the final result becomes a vaccine. The process is complicated and not playing games so the quality is maintained, ”said Dirga.
The process of making a vaccine starts from the researcher wanting to make a vaccine for a disease. Then, the vaccine must be tested on animals to ensure its safety and effectiveness. Only when it is proven safe and effective that testing is carried out on humans.
“In humans it is called clinical trials I, II and III. Later, even though there is a distribution permit, it will still be monitored in the fourth phase,” said Dirga in the Dialogue Protect Yourself During the Pandemic which was held at the Media Center Committee for the Handling of COVID-19 and National Economic Recovery (KPCPEN). ), Saturday (17/10/2020).
It does not stop there, even when a vaccine has received a distribution permit, the supervisory authority continuously monitors the safety of the vaccine. In Indonesia there is the Food and Drug Supervisory Agency (BPOM) as supervisor, then there is the Centers for Disease Control and Prevention (CDC) in the United States.
In times of extraordinary conditions such as the COVID-19 pandemic like now, the pharmaceutical industry is trying to find a vaccine. Even so, it does not abandon the principle of prudence and safety.
– .